| Literature DB >> 36013049 |
Michele Orsi1,2,3, Edgardo Somigliana1,2, Fulvia Milena Cribiù4,5, Gianluca Lopez4, Laura Buggio6, Manuela Wally Ossola1, Enrico Ferrazzi1,2.
Abstract
BACKGROUND: The epidemiology of adenomyosis has been traditionally based on patients undergoing hysterectomy for gynecological indications, while its prevalence among hysterectomies performed for obstetric complications is unknown. The aim of this study was to assess the prevalence and clinical impact of adenomyosis diagnosed through histology among women undergoing pregnancy-related hysterectomy (PH).Entities:
Keywords: adenomyosis; chorionamnionitis; endometriosis; placenta previa; pregnancy-related hysterectomy; preterm birth
Year: 2022 PMID: 36013049 PMCID: PMC9410253 DOI: 10.3390/jcm11164814
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flow diagram of study population.
Figure 2Macroscopic surgical specimen. The uterine cervix is indicated by the surgeon’s finger on the lower side. Above the cervix, the lower uterine segment is bulging because of the presence of placenta previa accreta with evidence of reduced myometrial thickness and massive neovascularization. On the upper uterine corpus, longitudinal caesarean section scar avoiding the placental edge is shown.
Figure 3Representative microphotograph of a post-partum uterus with adenomyosis. Hematoxilin and eosin (H&E), 1×. At low-power magnification, the placental implant is evident on the right, and with the underlying adenomyosis on the left.
Figure 4H&E, 4×. The decidualized adenomyosis focus demonstrated large endometrial glands, some with ectasia, and an underlying endometrial stroma.
Figure 5H&E, 10×. The glandular cells of the decidualized endometrium in the adenomyosis foci shows hypersecretive features, such as a clear cytoplasm.
Figure 6CD10, 10×. Immunohistochemistry for CD10 highlights the endometrial stroma.
Baseline characteristics of the study population stratified by presence or absence of adenomyosis.
| Characteristics | Adenomyosis | Non-A. | |||
|---|---|---|---|---|---|
| % or SD | % or SD | ||||
| Maternal age (years) | 39.7 | 5.2 | 37.6 | 4.5 | 0.08 |
| Country of origin | |||||
| Italy | 13 | 72.2 | 71 | 63.4 | 0.47 |
| Others | 5 | 27.8 | 41 | 36.6 | |
| Level of education | |||||
| Lower level | 5 | 27.8 | 12 | 10.7 | 0.1 |
| High school | 4 | 22.2 | 25 | 22.3 | 0.76 |
| University education | 6 | 33.3 | 45 | 40.2 | 0.58 |
| Missed | 3 | 16.7 | 30 | 26.8 | |
| Occupational status | |||||
| Working | 13 | 72.2 | 78 | 69.6 | 0.78 |
| No-working | 3 | 16.7 | 15 | 13.4 | |
| Missed | 2 | 11.1 | 19 | 17.0 | |
| Marital status | |||||
| Married | 12 | 66.7 | 78 | 69.6 | 0.8 |
| Unmarried | 6 | 33.3 | 34 | 30.4 | |
| Obstetric history | |||||
| Nulliparous | 15 | 83.3 | 84 | 75.0 | 0.44 |
| Previous vaginal delivery | 3 | 16.7 | 28 | 25.0 | 0.45 |
| One previous caesarean | 6 | 33.3 | 25 | 22.3 | 0.31 |
| Two or more previous caesarean | 4 | 22.2 | 27 | 24.1 | 0.86 |
| Previous curettage for abortion | 8 | 44.4 | 32 | 28.6 | 0.17 |
| Gynecological disease | |||||
| Previous surgery for uterine fibroid * | 2 | 11.1 | 6 | 5.4 | 0.35 |
| Uterine fibroid ** | 4 | 22.2 | 7 | 6.3 | 0.07 |
| Previous surgery for endometriosis *** | 3 | 16.7 | 3 | 2.7 | 0.004 |
| Previous adenomyomectomy **** | 1 | 5.6 | 0 | 0.0 | 0.13 |
| Endometriosis ** | 5 | 27.8 | 9 | 8.0 | 0.035 |
| Previous hysteroscopic metroplasty for uterine septum ***** | 3 | 16.7 | 2 | 1.8 | 0.017 |
Data are expressed as mean ± SD or Number and %. * Surgical technique (Adenomyosis/Non-A. group): Laparotomy (2/4); Laparoscopy (0/2); the endometrial cavity was involved in two cases of the Non-A group. ** Inclusion by medical history and post-PH histology. *** Surgical technique (Adenomyosis/Non-A. group): Laparotomy (1/0); Laparoscopy (2/3). **** Surgical technique: Laparotomy; the endometrial cavity was not involved. ***** Surgery was reported as unremarkable (no complications) in all cases.
Pregnancy outcome stratified by presence or absence of adenomyosis.
| Characteristics | Adenomyosis | Non-A. | |||
|---|---|---|---|---|---|
| % or SD | % or SD | ||||
| Pregnancy complications | |||||
| Twin gestation | 4 | 22.2 | 23 | 20.5 | 0.87 |
| Assisted reproductive technology | 9 | 50.0 | 22 | 19.6 | 0.01 |
| Hypertensive disorder of pregnancy | 1 | 5.6 | 10 | 8.9 | 0.71 |
| Placenta previa | 14 | 77.8 | 51 | 45.5 | 0.01 |
| Placenta accreta spectrum | 12 | 66.7 | 60 | 53.6 | 0.3 |
| Preterm premature rupture of membrane | 2 | 11.1 | 6 | 5.4 | 0.34 |
| Antepartum bleeding | 3 | 16.7 | 10 | 8.9 | 0.31 |
| Mode of delivery | |||||
| Vaginal delivery | 0 | 0.0 | 15 | 13.4 | 0.13 |
| Elective caesarean | 12 | 66.7 | 63 | 56.3 | 0.41 |
| Emergency caesarean | 6 | 33.3 | 34 | 30.4 | 0.8 |
| Clinical indication for hysterectomy | |||||
| Haemorrhage: placenta previa or accreta spectrum | 11 | 61.1 | 57 | 50.9 | 0.3 |
| Haemorrhage: uterine atony | 4 | 22.2 | 49 | 43.8 | 0.14 |
| Uterine rupture | 2 | 11.1 | 3 | 2.7 | 0.28 |
| Sepsis | 1 | 5.6 | 3 | 2.7 | 0.51 |
| Maternal and fetal outcomes | |||||
| Estimated blood loss (ml, SD) | 4072 | 2055.0 | 4726 | 3195.0 | 0.41 |
| Packed red cells units transfused | 7.3 | 5.6 | 9.5 | 6.4 | 0.17 |
| Major surgical complications * | 5 | 27.8 | 20 | 17.9 | 0.34 |
| Medical complications ** | 0 | 0.0 | 8 | 7.1 | 0.59 |
| Gestational age at delivery (weeks, SD) | 32 | 4.6 | 35.5 | 3.6 | 0.0004 |
| Small for gestational age at birth | 2 | 11.1 | 7 | 6.3 | 0.6 |
| Chorionamnionitis | 5 | 27.8 | 6 | 5.4 | 0.008 |
| Stillbirth | 2 | 11.1 | 1 | 0.9 | 0.07 |
| Intrauterine fetal demise in twin pregnancy | 2 | 50.0 | 1 | 4.5 | 0.048 |
Data are expressed as mean ± SD or Number and %. * Urinary tract lesion, relaparotomy. ** Disseminated intravascular coagulation, haemorrhagic shock, kidney failure.